share_log

Morgan Stanley Maintains Equal-Weight on Anterix, Lowers Price Target to $41

Morgan Stanley Maintains Equal-Weight on Anterix, Lowers Price Target to $41

摩根士丹利维持Anterix的同等权重,将目标股价下调至41美元
Benzinga ·  2023/08/01 10:39

Morgan Stanley analyst Nigel Dally maintains Anterix (NASDAQ:ATEX) with a Equal-Weight and lowers the price target from $42 to $41.

摩根士丹利分析师奈杰尔·达利维持Anterix(纳斯达克:ATEX)的同等权重,并将目标价从42美元下调至41美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发